The trademark AsperiaZen was filed by NatuGena GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on September 7, 2022, and received one opposition filed on December 7, 2022 by Dentinox Gesellschaft für pharmazeutische Präparate Lenk & Schuppan KG on Likelihood of confusion. the opponent was represented by GRÜNECKER and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 7, 2022
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on September 15, 2022. Change of name and address of the trademark registration was recorded on November 19, 2023.